Five key notes:
1. The Alpha Omega system aims to guide electrodes of intra-brain stimulation systems and were previously independently marketed to hospitals. Now, they could be sold as part of a treatment package.
2. Prior to the deal, Medtronic marketed its own electrodes system along with its surgical guidance system in competition with Alpha Omega, but the report states all Israel-based medical centers that include deep brain stimulation use the Alpha Omega product.
3. Alpha Omega reports more than $10 million in annual revenue while Medtronic has a market cap of $114 billion.
4. This isn’t Medtronic’s first foray into Israel; the company previously partnered with Mazor Robotics, a company focused on spinal robotics, which it acquired for $1.64 billion.
More articles on technology:
Orthopedic imaging in 2019 – Key thoughts from EOS imaging CEO Mike Lobinsky
NuVasive introduces new spine surgery technology & more: 5 device company notes
Stryker brings SpineMap Go software to market: 3 quick points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
